Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP263680.RAXcKHLAia7K4Y6K6sTICBqzHWUi8HGcHCmkmwQ44U6fI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP263680.RAXcKHLAia7K4Y6K6sTICBqzHWUi8HGcHCmkmwQ44U6fI130_assertion type Assertion NP263680.RAXcKHLAia7K4Y6K6sTICBqzHWUi8HGcHCmkmwQ44U6fI130_head.
- NP263680.RAXcKHLAia7K4Y6K6sTICBqzHWUi8HGcHCmkmwQ44U6fI130_assertion description "[A daily subcutaneous infusion of 18-base, fully phosporothioated antisense oligonucleotide was administered for 2 weeks to nine patients who had BCL-2-positive relapsed non-Hodgkin lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP263680.RAXcKHLAia7K4Y6K6sTICBqzHWUi8HGcHCmkmwQ44U6fI130_provenance.
- NP263680.RAXcKHLAia7K4Y6K6sTICBqzHWUi8HGcHCmkmwQ44U6fI130_assertion evidence source_evidence_literature NP263680.RAXcKHLAia7K4Y6K6sTICBqzHWUi8HGcHCmkmwQ44U6fI130_provenance.
- NP263680.RAXcKHLAia7K4Y6K6sTICBqzHWUi8HGcHCmkmwQ44U6fI130_assertion SIO_000772 9113013 NP263680.RAXcKHLAia7K4Y6K6sTICBqzHWUi8HGcHCmkmwQ44U6fI130_provenance.
- NP263680.RAXcKHLAia7K4Y6K6sTICBqzHWUi8HGcHCmkmwQ44U6fI130_assertion wasDerivedFrom befree-20150227 NP263680.RAXcKHLAia7K4Y6K6sTICBqzHWUi8HGcHCmkmwQ44U6fI130_provenance.
- NP263680.RAXcKHLAia7K4Y6K6sTICBqzHWUi8HGcHCmkmwQ44U6fI130_assertion wasGeneratedBy ECO_0000203 NP263680.RAXcKHLAia7K4Y6K6sTICBqzHWUi8HGcHCmkmwQ44U6fI130_provenance.